AVITA Medical (RCEL) News Today $5.99 -0.12 (-1.96%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$5.98 0.00 (-0.08%) As of 06/10/2025 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RCEL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period AVITA Medical (NASDAQ:RCEL) Given Buy Rating at D. Boral CapitalD. Boral Capital reissued a "buy" rating and issued a $19.00 price objective on shares of AVITA Medical in a research note on Friday.June 6, 2025 | marketbeat.comAVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™June 5, 2025 | finance.yahoo.comAVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough AwardsJune 3, 2025 | globenewswire.comShort Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Rises By 23.9%AVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 3,680,000 shares, a growth of 23.9% from the April 30th total of 2,970,000 shares. Based on an average trading volume of 231,200 shares, the days-to-cover ratio is currently 15.9 days. Approximately 14.9% of the shares of the stock are short sold.June 3, 2025 | marketbeat.comDelta Investment Management LLC Increases Holdings in AVITA Medical, Inc. (NASDAQ:RCEL)Delta Investment Management LLC raised its position in AVITA Medical, Inc. (NASDAQ:RCEL - Free Report) by 263.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 52,470 shares of the company's stock aftMay 22, 2025 | marketbeat.comCantor Fitzgerald Comments on AVITA Medical FY2025 EarningsAVITA Medical, Inc. (NASDAQ:RCEL - Free Report) - Analysts at Cantor Fitzgerald increased their FY2025 earnings per share (EPS) estimates for AVITA Medical in a research note issued on Monday, May 12th. Cantor Fitzgerald analyst R. Osborn now forecasts that the company will earn ($0.99) per shareMay 16, 2025 | marketbeat.comAVITA Medical’s Acute Wound Care Showcase 2025 Streams Live TodayMay 13, 2025 | finance.yahoo.comAVITA Medical: Near-Perfect Execution Needed To Navigate Through Balance Sheet ChallengesMay 12, 2025 | seekingalpha.comAnalysts Have Been Trimming Their AVITA Medical, Inc. (NASDAQ:RCEL) Price Target After Its Latest ReportMay 11, 2025 | finance.yahoo.comAVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comAVITA Medical Reports First Quarter 2025 Financial ResultsMay 8, 2025 | globenewswire.comAVITA Medical (RCEL) Expected to Announce Quarterly Earnings on ThursdayAVITA Medical (NASDAQ:RCEL) will be releasing its Q1 2025 earnings after the market closes on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-avita-medical-inc-stock/)May 3, 2025 | marketbeat.comAVITA Medical to Announce First Quarter 2025 Financial ResultsApril 17, 2025 | globenewswire.comAVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025April 9, 2025 | globenewswire.com6 Analysts Assess AVITA Medical: What You Need To KnowApril 6, 2025 | nasdaq.comAVITA Medical (NASDAQ:RCEL) Receives "Buy" Rating from D. Boral CapitalD. Boral Capital reissued a "buy" rating and issued a $22.00 price objective on shares of AVITA Medical in a research report on Friday.April 6, 2025 | marketbeat.comAvita Medical announces U.S. commercial launch of CohealyxApril 4, 2025 | msn.comAVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market OpportunityApril 3, 2025 | globenewswire.comAVITA Medical, Inc. (NASDAQ:RCEL) Sees Large Growth in Short InterestAVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,350,000 shares, a growth of 35.8% from the February 28th total of 1,730,000 shares. Currently, 9.5% of the company's stock are sold short. Based on an average daily trading volume, of 215,900 shares, the days-to-cover ratio is currently 10.9 days.April 1, 2025 | marketbeat.comAVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdlesMarch 21, 2025 | uk.investing.comAVITA Medical (NASDAQ:RCEL) Earns Buy Rating from D. Boral CapitalD. Boral Capital reissued a "buy" rating and issued a $22.00 target price on shares of AVITA Medical in a research report on Tuesday.March 19, 2025 | marketbeat.com4RCEL : What Analysts Are Saying About AVITA Medical StockMarch 18, 2025 | benzinga.comAvita Medical amends PermeaDerm distribution agreement with Stedical ScientificMarch 17, 2025 | markets.businessinsider.comAvita Medical Boosts Production with New AgreementMarch 17, 2025 | tipranks.comAVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical ScientificMarch 17, 2025 | globenewswire.comDoes Avita Medical (RCEL) Have the Potential to Rally 73.72% as Wall Street Analysts Expect?March 13, 2025 | msn.comAvita Medical management to meet with Lake StreetFebruary 27, 2025 | markets.businessinsider.comAVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care ConferenceFebruary 26, 2025 | globenewswire.comAVITA Medical, Inc. (NASDAQ:RCEL) Director Robert Mcnamara Purchases 10,000 SharesAVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) Director Robert Mcnamara acquired 10,000 shares of the stock in a transaction that occurred on Thursday, February 20th. The stock was purchased at an average cost of $10.09 per share, with a total value of $100,900.00. Following the completion of the acquisition, the director now owns 45,749 shares of the company's stock, valued at $461,607.41. The trade was a 27.97 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.February 21, 2025 | marketbeat.comD. Boral Capital Has Lowered Expectations for AVITA Medical (NASDAQ:RCEL) Stock PriceD. Boral Capital lowered their price target on AVITA Medical from $25.00 to $22.00 and set a "buy" rating for the company in a research report on Thursday.February 21, 2025 | marketbeat.comAVITA Medical, Inc. (NASDAQ:RCEL) CFO Purchases $10,250.00 in StockAVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) CFO David D. O'toole bought 1,000 shares of AVITA Medical stock in a transaction on Wednesday, February 19th. The stock was acquired at an average price of $10.25 per share, for a total transaction of $10,250.00. Following the purchase, the chief financial officer now owns 24,734 shares of the company's stock, valued at approximately $253,523.50. This trade represents a 4.21 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.February 20, 2025 | marketbeat.comAvita Medical price target lowered to $22 from $25 at D. Boral CapitalFebruary 20, 2025 | markets.businessinsider.comAVITA Medical, Inc. (RCEL): A Bull Case TheoryFebruary 20, 2025 | insidermonkey.comDavid D. O'toole Buys 1,000 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) StockFebruary 20, 2025 | insidertrades.comAVITA Medical (RCEL) Expected to Announce Earnings on ThursdayAVITA Medical (NASDAQ:RCEL) will be releasing earnings after the market closes on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=655168)February 20, 2025 | marketbeat.comAfter Sales Rebound In January, AVITA Is Set Up For A Monster YearFebruary 18, 2025 | seekingalpha.comAVITA Medical's (RCEL) Buy Rating Reiterated at D. Boral CapitalD. Boral Capital reiterated a "buy" rating and issued a $25.00 target price on shares of AVITA Medical in a research note on Friday.February 15, 2025 | marketbeat.comAvita Medical price target lowered to $11 from $12 at Piper SandlerFebruary 15, 2025 | markets.businessinsider.comAVITA Medical (NASDAQ:RCEL) Posts Earnings Results, Misses Estimates By $0.14 EPSAVITA Medical (NASDAQ:RCEL - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.44) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.14). AVITA Medical had a negative net margin of 95.47% and a negative return on equity of 194.69%.February 14, 2025 | marketbeat.comAVITA Medical to Host Investor Webinar BriefingFebruary 14, 2025 | globenewswire.comAVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call TranscriptFebruary 13, 2025 | seekingalpha.comAVITA Medical Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 13, 2025 | globenewswire.comCantor Fitzgerald Estimates AVITA Medical FY2024 EarningsAVITA Medical, Inc. (NASDAQ:RCEL - Free Report) - Stock analysts at Cantor Fitzgerald decreased their FY2024 EPS estimates for shares of AVITA Medical in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will earn ($2.51) per share foJanuary 23, 2025 | marketbeat.comCantor Fitzgerald Forecasts AVITA Medical FY2025 EarningsAVITA Medical, Inc. (NASDAQ:RCEL - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of AVITA Medical in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn anticipates that the company wilJanuary 22, 2025 | marketbeat.comAVITA Medical, Inc. (NASDAQ:RCEL) Holdings Boosted by Barclays PLCBarclays PLC grew its stake in shares of AVITA Medical, Inc. (NASDAQ:RCEL - Free Report) by 340.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,503 shares of the company's stock after purchasing an additional 28,979January 19, 2025 | marketbeat.comShort Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Rises By 25.9%AVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,460,000 shares, an increase of 25.9% from the December 15th total of 1,160,000 shares. Currently, 5.9% of the company's shares are short sold. Based on an average daily volume of 132,500 shares, the short-interest ratio is currently 11.0 days.January 18, 2025 | marketbeat.comInvestors Burned By AVITA Medical's Sales Miss: I'm Even More BullishJanuary 12, 2025 | seekingalpha.comAVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO MiniJanuary 10, 2025 | seekingalpha.comAvita Medical price target lowered to $14 from $20 at Lake StreetJanuary 10, 2025 | markets.businessinsider.comAVITA Medical, Inc. (RCEL): A Bull Case TheoryJanuary 9, 2025 | insidermonkey.com Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address RCEL Media Mentions By Week RCEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCEL News Sentiment▼0.391.01▲Average Medical News Sentiment RCEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCEL Articles This Week▼52▲RCEL Articles Average Week Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CeriBell News Butterfly Network News RxSight News Avanos Medical News Embecta News Delcath Systems News Bioventus News OrthoPediatrics News AxoGen News NeuroPace News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCEL) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
